0000950170-24-094132.txt : 20240808
0000950170-24-094132.hdr.sgml : 20240808
20240808164845
ACCESSION NUMBER: 0000950170-24-094132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240807
FILED AS OF DATE: 20240808
DATE AS OF CHANGE: 20240808
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: D'Onofrio Matthew J
CENTRAL INDEX KEY: 0001578770
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 241189256
MAIL ADDRESS:
STREET 1: C/O EVOKE PHARMA, INC.
STREET 2: 505 LOMAS SANTA FE DRIVE
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
4
1
ownership.xml
4
X0508
4
2024-08-07
0001403708
Evoke Pharma Inc
EVOK
0001578770
D'Onofrio Matthew J
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 230
SOLANA BEACH
CA
92075
true
true
false
false
Chief Executive Officer
false
Stock Option (Right to Buy)
5.27
2024-08-07
4
A
false
64840
0
A
2034-08-06
Common Stock
64840
64840
D
50% of the total number of shares subject to the options shall vest on the 18th month anniversary of August 7, 2024 (the "Vesting Commencement Date"), and 1/36th of the other 50% of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.
/s/ Matthew J. D'Onofrio
2024-08-08